๐จ AOECS has published an updated position paper on gluten in medicines, cosmetics, and hygiene products. While gluten in these items poses minimal risk to coeliacs, the paper provides important guidance for patients, doctors, and manufacturers. Stay informed and make safe choices! ๐ #CeliacDisease #GlutenFreeAlliance #AOECS #together4coeliacs
The Association of European Coeliac Societies (AOECS) urges the Codex Committee on Food Labelling to include gluten in its new Precautionary Allergen Labelling (PAL) guidelines. AOECS warns that excluding gluten risks both safety and choice for coeliac patients. The call comes ahead of the Codex meeting in Quรฉbec City starting on 27 October 2024.
๐จ Deadline Extended! ๐จ Weโre giving researchers extra time to submit abstracts for the AOECS Call for Scientific Papers on coeliac disease. The new deadline is September 23, 2024! Donโt miss this chance to showcase your research at our Annual Conference in Madrid this November. Letโs work together to advance the understanding of coeliac disease and improve lives. ๐
The Association of European Coeliac Societies (AOECS) will bring the patient perspective to the International Coeliac Disease Symposium in Sheffield, UK, from September 5-7, 2024. AOECS Vice Chair Floris van Overveld is set to speak on September 7, emphasizing the need for research that addresses both the medical and social challenges faced by those living with coeliac disease.
Researchers from the Technical University of Munich have confirmed that gluten can migrate from certain biodegradable food contact materials (FCMs) into gluten-free foods, posing a risk to individuals with coeliac disease. The study found gluten levels as high as 203 mg/L in liquids exposed to wheat bran-based plates, significantly exceeding safe limits. Caution is advised for coeliacs.
๐ข Have exciting research on coeliac disease? Share your findings with the global coeliac community! ๐ Submit your abstract by September 9, 2024, for a chance to present at the AOECS Annual Conference in Madrid. ๐ช๐ธ Learn more about how to join this call on our website www.aoecs.org. Don't miss out! ๐ฌ๐
๐ข Join us for Spain's inaugural Parliamentary Day on Coeliac Disease! ๐ช๐ธ On May 16th, we'll raise awareness and discuss advancements in research and clinical practices. Tune in live from 10:00 to 13:30 CET. #CoeliacAwarenessDay #AOECS #glutenfreealliance ๐พโจ
Join AOECS and AIC at the Senate of the Italian Republic on May 14th as they spotlight Coeliac Awareness Day. Led by Italian Senator Elena Murelli, this event amplifies the voices of those affected by coeliac disease, advocating for crucial awareness and support.
For consumers with celiac disease, it is important to be able to detect if food contains gluten. Precautionary allergen labelling (PAL) is a voluntary labelling practice used by food manufacturers to communicate the potential presence of allergens in food products that are not intentionally added as ingredients. AOECS advocates for further clarity and consistency for consumer-friendly labelling.
AOECS seeks clarification from the European Commission on a proposed change in Regulation (EC) No 1333/2008. This is a key piece of legislation within the European Union that governs the use of food additives (e.g. that can replace gluten). AOECS accepts the suggested change, but the main concern is if the current rules remain unchanged despite a new categorization.
Three independent studies from Coeliac Societies revealed gluten can migrate from food contact materials into gluten-free food. European Commission now assures ongoing preparatory efforts toward revising European Food Contact Material regulations to enhance consumer information, including labeling requirements and stricter rules on substance migration into food.
As artificial intelligence is being more widely used in healthcare, AOECS needs to stay alert to future developments. This became evident when Veronica Rubio, Secretary General of the Association of European Coeliac Societies (AOECS), and Tunde Koltai, Chair of the Board, attended the European Patient Forum Leadership Meeting centered on Artificial Intelligence on April 13th, 2024.